Chemotherapy and Inflammatory Cytokine Signalling in Cancer Cells and the Tumour Microenvironment.

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-030-20301-6_9PMID 31456184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysregulation of cytokine mediated chemotherapy induced cognitive impairment

  2017cited by this paper
• IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells

  2017cited by this paper
• A Feedback Loop Between miR-30a/c-5p and DNMT1 Mediates Cisplatin Resistance in Ovarian Cancer Cells

  2017cited by this paper
• 5‐Fluorouracil chemotherapy upregulates cytokines and alters hippocampal dendritic complexity in aged mice

  2017cited by this paper
• Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy☆

  2017cited by this paper
• Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance

  2017cited by this paper
• Cytokines in immunogenic cell death: Applications for cancer immunotherapy

  2017cited by this paper
• The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells

  2017cited by this paper
• Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers

  2016cited by this paper
• CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks

  2016cited by this paper
• Paclitaxel-induced epithelial damage and ectopic MMP-13 expression promotes neurotoxicity in zebrafish

  2016cited by this paper
• Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment

  2016cited by this paper
• Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma

  2016cited by this paper
• ZNF32 contributes to the induction of multidrug resistance by regulating TGF-β receptor 2 signaling in lung adenocarcinoma

  2016cited by this paper
• Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell

  2016cited by this paper
• Targeting the CCL2-CCR2 signaling axis in cancer metastasis

  2016cited by this paper
• Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells

  2016cited by this paper
• Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways.

  2016cited by this paper
• Role of interleukin-6 in cancer progression and therapeutic resistance

  2016cited by this paper
• Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma

  2016cited by this paper
• Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs.

  2016cited by this paper
• Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells.

  2016cited by this paper
• IL-6 Inhibition Reduces STAT3 Activation and Enhances the Antitumor Effect of Carboplatin

  2016cited by this paper
• Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases.

  2016cited by this paper
• Acquisition of Chemoresistance and Other Malignancy-related Features of Colorectal Cancer Cells Are Incremented by Ribosome-inactivating Stress*

  2016cited by this paper
• Cytokines in cancer drug resistance: Cues to new therapeutic strategies.

  2016cited by this paper
• Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance.

  2016cited by this paper
• Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

  2015cited by this paper
• Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer

  2015cited by this paper
• MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients

  2015cited by this paper
• Inhibition of the autocrine IL-6–JAK2–STAT3–calprotectin axis as targeted therapy for HR−/HER2+ breast cancers

  2015cited by this paper
• Interleukin-18 Down-Regulates Multidrug Resistance-Associated Protein 2 Expression through Farnesoid X Receptor Associated with Nuclear Factor Kappa B and Yin Yang 1 in Human Hepatoma HepG2 Cells

  2015cited by this paper
• Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma

  2015cited by this paper
• Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines

  2015cited by this paper
• The paradoxical role of IL-10 in immunity and cancer.

  2015cited by this paper
• ROS-Induced CXCR4 Signaling Regulates Mantle Cell Lymphoma (MCL) Cell Survival and Drug Resistance in the Bone Marrow Microenvironment via Autophagy

  2015cited by this paper
• TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma.

  2015cited by this paper
• Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy.

  2015cited by this paper
• IL6 induces TAM resistance via kinase-specific phosphorylation of ERα in OVCA cells.

  2015cited by this paper
• Inflammation and cancer: advances and new agents

  2015cited by this paper
• Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway

  2015cited by this paper
• Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study†

  2015cited by this paper
• The Role of Cytokines in Breast Cancer Development and Progression

  2015cited by this paper
• IL-24 Induces Apoptosis via Upregulation of RNA-Activated Protein Kinase and Enhances Temozolomide-Induced Apoptosis in Glioma Cells

  2015cited by this paper
• Expression of CCL2 is significantly different in five breast cancer genotypes and predicts patient outcome.

  2015cited by this paper
• CCR9–CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway

  2015cited by this paper
• Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells.

  2015cited by this paper
• Context‐dependent role of IL‐18 in cancer biology and counter‐regulation by IL‐18BP

  2015cited by this paper
• Immunity, inflammation, and cancer: an eternal fight between good and evil.

  2015cited by this paper
• IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and dna repair associated molecules

  2015cited by this paper
• IL-6 as a keystone cytokine in health and disease

  2015cited by this paper
• Oncolytic adenovirus‑mediated mda‑7/IL‑24 expression suppresses osteosarcoma growth and enhances sensitivity to doxorubicin.

  2015cited by this paper
• CXCR4 in breast cancer: oncogenic role and therapeutic targeting

  2015cited by this paper
• Chemokines in Cancer Development and Progression and Their Potential as Targeting Molecules for Cancer Treatment

  2014cited by this paper
• Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease.

  2014cited by this paper
• Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis

  2014cited by this paper
• Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells

  2014cited by this paper
• Downregulation of Blood-Brain Barrier Phenotype by Proinflammatory Cytokines Involves NADPH Oxidase-Dependent ROS Generation: Consequences for Interendothelial Adherens and Tight Junctions

  2014cited by this paper
• The potential to target CCL5/CCR5 in breast cancer

  2014cited by this paper
• Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation

  2014cited by this paper
• Cytokines driving breast cancer stemness.

  2014cited by this paper
• Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.

  2014cited by this paper
• The Inflammatory Chemokine CCL5 and Cancer Progression

  2014cited by this paper
• Sensitizing B- and T- cell Lymphoma Cells to Paclitaxel/Abraxane–Induced Death by AS101 via Inhibition of the VLA-4–IL10–Survivin Axis

  2014cited by this paper
• CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1

  2014cited by this paper
• Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loop

  2014cited by this paper
• Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression

  2014cited by this paper
• Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

  2014cited by this paper
• MiR-379/411 cluster regulates IL-18 and contributes to drug resistance in malignant pleural mesothelioma.

  2014cited by this paper
• Monocyte Chemotactic Protein 1 (MCP-1) Modulates Pro-Survival Signaling to Promote Progression of Head and Neck Squamous Cell Carcinoma

  2014cited by this paper
• The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets

  2014cited by this paper
• Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells

  2014cited by this paper
• Interleukin 7 signaling prevents apoptosis by regulating bcl-2 and bax via the p53 pathway in human non-small cell lung cancer cells.

  2014cited by this paper
• Recombinant human interleukin 24 reverses Adriamycin resistance in a human breast cancer cell line

  2014cited by this paper
• Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers

  2014cited by this paper
• Mechanisms of Adipocytokine-Mediated Trastuzumab Resistance in HER2-Positive Breast Cancer Cell Lines.

  2013cited by this paper
• Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

  2013cited by this paper
• Articles on similar topics can be found in the following Blood collections

  2013cited by this paper
• An oncolytic adenovirus expressing interleukin-24 enhances antitumor activities in combination with paclitaxel in breast cancer cells.

  2013cited by this paper
• Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer.

  2013cited by this paper
• Colony-stimulating factors for febrile neutropenia during cancer therapy.

  2013cited by this paper
• Molecular targets and signaling pathways regulated by interleukin (IL)-24 in mediating its antitumor activities

  2013cited by this paper
• PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Mast cell and macrophage chemokines CXCL 1 / CXCL 2 control the early stage of neutrophil recruitment during tissue in fl ammation

  2013cited by this paper
• Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms

  2013cited by this paper
• The TGFbeta Superfamily Signaling Pathway

  2013cited by this paper
• Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma.

  2013cited by this paper
• Dynamic Chemotherapy-Induced Upregulation of CXCR4 Expression: A Mechanism of Therapeutic Resistance in Pediatric AML

  2013cited by this paper
• Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

  2013cited by this paper
• Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of twist1, YB‐1, and androgen receptor

  2013cited by this paper
• Membrane versus soluble isoforms of TNF-α exert opposing effects on tumor growth and survival of tumor-associated myeloid cells.

  2013cited by this paper
• Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8.

  2013cited by this paper
• Resistance to Anthracyclines and Taxanes in Breast Cancer

  2013cited by this paper
• Marked improvement of cytotoxic effects induced by docetaxel on highly metastatic and androgen-independent prostate cancer cells by downregulating macrophage inhibitory cytokine-1

  2013cited by this paper
• Dual role of immunomodulation by anticancer chemotherapy

  2013cited by this paper
• The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1.

  2013cited by this paper
• MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling.

  2012cited by this paper
• CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.

  2012cited by this paper
• CCL2/CCR2 Chemokine Signaling Coordinates Survival and Motility of Breast Cancer Cells through Smad3 Protein- and p42/44 Mitogen-activated Protein Kinase (MAPK)-dependent Mechanisms*

  2012cited by this paper
• The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis

  2012cited by this paper
• A CXCL1 paracrine network links cancer chemoresistance and metastasis.

  2012cited by this paper

• Epithelial–Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical Implications

  2025cites this paper
• From cold to hot: mechanisms of hyperthermia in modulating tumor immunology for enhanced immunotherapy

  2025cites this paper
• Infection Biomarkers in Children with Chemotherapy-Induced Severe Neutropenia

  2025cites this paper
• Lycopene mitigates paclitaxel-induced cognitive impairment in mice; Insights into Nrf2/HO-1, NF-κB/NLRP3, and GRP-78/ATF-6 axes.

  2025cites this paper
• A novel cuproptosis-associated LncRNA model predicting prognostic and immunotherapy response for glioma

  2025cites this paper
• Plasma IFN-γ may predict pyrotinib efficacy in patients with HER2-positive advanced breast cancer

  2025cites this paper
• Xanthatin nanocrystals exert anti-inflammatory properties against TNFα-primed 2D monolayers and in 3D spheroids of human HT29 colorectal cancer cells

  2025cites this paper
• EEG as a predictive biomarker of neurotoxicity in anti-CD19 CAR T-cell therapy

  2025cites this paper
• Unveiling the Role of GRK2: From Immune Regulation to Cancer Therapeutics

  2025cites this paper
• Expression of chemokine receptor 5 in acute myeloid leukemia

  2025cites this paper
• Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer.

  2024cites this paper
• Magnetic resonance imaging radiomics-based prediction of severe inflammatory response in locally advanced rectal cancer patients after neoadjuvant radiochemotherapy

  2024cites this paper
• SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis

  2024cites this paper
• Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision Medicine

  2024cites this paper
• Identification and prognostic evaluation of differentially expressed long noncoding RNAs associated with immune infiltration in osteosarcoma

  2024cites this paper
• Impact of Doxorubicin and Docetaxel on Immune Checkpoint Expression in Colorectal Cancer: Insights into Chemotherapy Resistance Mechanisms

  2024cites this paper
• Systemic Inflammation in Oncologic Patients Undergoing Systemic Treatment and Receiving Whey Protein-Based Nutritional Support

  2024cites this paper
• System biology analysis to develop diagnostic biomarkers, monitoring pathological indexes, and novel therapeutic approaches for immune targeting based on maggot bioactive compounds and polyphenolic cocktails in mice with gastric cancer.

  2023cites this paper
• Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells

  2022cites this paper
• Circ_0016347 modulates proliferation, migration, invasion, cell cycle, and apoptosis of osteosarcoma cells via the miR-661/IL6R axis

  2022cites this paper
• The synergistic antitumor effect of IL-6 neutralization with NVP-BEZ235 in hepatocellular carcinoma

  2022cites this paper
• Potential Molecular Biomarkers of Central Nervous System Damage in Breast Cancer Survivors

  2022cites this paper
• GM-CSF-miRNA-Jak2/Stat3 Signaling Mediates Chemotherapy-Induced Cancer Cell Stemness in Gastric Cancer

  2022cites this paper
• Role of the Pro-Inflammatory Tumor Microenvironment in Extracellular Vesicle-Mediated Transfer of Therapy Resistance

  2022cites this paper
• Two-dimensional nanomaterials for tumor microenvironment modulation and anticancer therapy.

  2022cites this paper
• Single-Cell Transcriptome Analysis Reveals Changes of Tumor Immune Microenvironment in Oral Squamous Cell Carcinoma After Chemotherapy

  2022cites this paper
• The Relationship Between Exacerbation of Pachymeningitis and Chemotherapy: A Case Report

  2022cites this paper
• Synergistic effects of nab-PTX and anti-PD-1 antibody combination against lung cancer by regulating the Pi3K/AKT pathway through the Serpinc1 gene

  2022cites this paper
• Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma

  2022cites this paper
• Circadian disruption and cancer- and treatment-related symptoms

  2022cites this paper
• Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.

  2021cites this paper
• Does the Chemotherapy Protocol Affect CXCL12/CXCR4 Axes in Acute Myeloid Leukemia Patients with Monocytic Differentiation?

  2021cites this paper
• Cytokines in various molecular subtypes of breast cancer

  2021cites this paper
• Effect of Chemotherapy on Serum Level of CCL2 in Acute Myeloid Leukemia Patients with Monocytic Differentiation

  2021cites this paper
• The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma

  2021cites this paper
• Cytokine Profiling in Plasma from Patients with Brain Tumors Versus Healthy Individuals using 2 Different Multiplex Immunoassay Platforms

  2021cites this paper
• TNF-alpha Induces Pro-Inflammatory Factors in Colorectal Cancer Microenvironment

  2020cites this paper
• Oridonin exhibits anti-angiogenic activity in human umbilical vein endothelial cells by inhibiting VEGF-induced VEGFR-2 signaling pathway.

  2020cites this paper
• Differential regulatory effects of chemotherapeutic protocol on CCL3_CCL4_CCL5/CCR5 axes in acute myeloid leukemia patients with monocytic lineage.

  2019cites this paper